These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36839790)

  • 21. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery.
    Prosperi-Porta G; Kedzior S; Muirhead B; Sheardown H
    Biomacromolecules; 2016 Apr; 17(4):1449-57. PubMed ID: 26963738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogel Biomaterials for Application in Ocular Drug Delivery.
    Lynch CR; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
    Front Bioeng Biotechnol; 2020; 8():228. PubMed ID: 32266248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies to prolong the residence time of drug delivery systems on ocular surface.
    Grassiri B; Zambito Y; Bernkop-Schnürch A
    Adv Colloid Interface Sci; 2021 Feb; 288():102342. PubMed ID: 33444845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of prednisolone-containing eye drop formulations by cyclodextrin complexation and antimicrobial, mucoadhesive biopolymer.
    Bíró T; Horvát G; Budai-Szűcs M; Csányi E; Urbán E; Facskó A; Szabó-Révész P; Csóka I; Aigner Z
    Drug Des Devel Ther; 2018; 12():2529-2537. PubMed ID: 30147300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: Synthesis, in vitro/vivo evaluation, and mechanism.
    Sun X; Sheng Y; Li K; Sai S; Feng J; Li Y; Zhang J; Han J; Tian B
    Acta Biomater; 2022 Jan; 138():193-207. PubMed ID: 34757228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tear fluid-eye drops compatibility assessment using surface tension.
    Hotujac Grgurević M; Juretić M; Hafner A; Lovrić J; Pepić I
    Drug Dev Ind Pharm; 2017 Feb; 43(2):275-282. PubMed ID: 27645109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease.
    Srinivasan S; Williams R
    Clin Ophthalmol; 2022; 16():3311-3326. PubMed ID: 36237486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyacrylic acid/polyvinylpyrrolidone bipolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome.
    Oechsner M; Keipert S
    Eur J Pharm Biopharm; 1999 Mar; 47(2):113-8. PubMed ID: 10234534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations.
    Nakamura S; Okada S; Umeda Y; Saito F
    Cornea; 2004 May; 23(4):390-7. PubMed ID: 15097136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Review on Dry Eye Disease Treatment: Recent Progress, Diagnostics, and Future Perspectives.
    Mondal H; Kim HJ; Mohanto N; Jee JP
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the influence of surface properties of nanoparticles and penetration enhancers for improving bioavailability in eye tissues in vivo.
    Mahaling B; Katti DS
    Int J Pharm; 2016 Mar; 501(1-2):1-9. PubMed ID: 26821059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage.
    Liu S; Dozois MD; Chang CN; Ahmad A; Ng DL; Hileeto D; Liang H; Reyad MM; Boyd S; Jones LW; Gu FX
    Mol Pharm; 2016 Sep; 13(9):2897-905. PubMed ID: 27482595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parametric Drug Release Optimization of Anti-Inflammatory Drugs by Gold Nanoparticles for Topically Applied Ocular Therapy.
    Raiche-Marcoux G; Loiseau A; Maranda C; Poliquin A; Boisselier E
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
    Gade SK; Shivshetty N; Sharma N; Bhatnagar S; Garg P; Venuganti VVK
    J Ocul Pharmacol Ther; 2018 Oct; 34(8):570-578. PubMed ID: 30136888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New vehicle based on a microemulsion for topical ocular administration of dexamethasone.
    Fialho SL; da Silva-Cunha A
    Clin Exp Ophthalmol; 2004 Dec; 32(6):626-32. PubMed ID: 15575833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Approach in Ocular Drug Delivery: In vitro and ex vivo Investigation of Cyclodextrin-Containing, Mucoadhesive Eye Drop Formulations.
    Bíró T; Bocsik A; Jurišić Dukovski B; Gróf I; Lovrić J; Csóka I; Deli MA; Aigner Z
    Drug Des Devel Ther; 2021; 15():351-360. PubMed ID: 33568896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivitis: an open-label study.
    Dogru M; Ozmen A; Ertürk H; Sanli O; Karatas A
    Clin Ther; 2002 Aug; 24(8):1309-21. PubMed ID: 12240781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.